These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31661651)

  • 1. Comparison of Chemokine CXCL-1 and Interleukin-6 Concentrations in the Subretinal Fluid and Vitreous in Rhegmatogenous Retinal Detachment.
    Symeonidis C; Rotsos T; Matsou A; Dermenoudi M; Georgalas I; Tsinopoulos I; Makri O; Souliou E; Dimitrakos SA
    Ocul Immunol Inflamm; 2021 Feb; 29(2):355-361. PubMed ID: 31661651
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of interleukin-6 and matrix metalloproteinase expression in the subretinal fluid and the vitreous during proliferative vitreoretinopathy: correlations with extent, duration of RRD and PVR grade.
    Symeonidis C; Papakonstantinou E; Androudi S; Georgalas I; Rotsos T; Karakiulakis G; Diza E; Dimitrakos SA
    Cytokine; 2014 Jun; 67(2):71-6. PubMed ID: 24725542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine CXCL-1 expression in the subretinal fluid during rhegmatogenous retinal detachment.
    Symeonidis C; Androudi S; Rotsos T; Moschos MM; Souliou E; Dimitrakos SA; Diza E
    Ocul Immunol Inflamm; 2014 Dec; 22(6):449-53. PubMed ID: 24354433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine CXCL-1: activity in the vitreous during proliferative vitreoretinopathy.
    Symeonidis C; Androudi S; Georgalas I; Tzamalis A; Chalvatzis N; Rotsos T; Souliou E; Diza E; Dimitrakos SA
    Clin Exp Immunol; 2015 Aug; 181(2):338-42. PubMed ID: 25766782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 and matrix metalloproteinase expression in the subretinal fluid during proliferative vitreoretinopathy: correlation with extent, duration of RRD and PVR grade.
    Symeonidis C; Papakonstantinou E; Androudi S; Tsaousis KT; Tsinopoulos I; Brazitikos P; Karakiulakis G; Diza E; Dimitrakos SA
    Cytokine; 2012 Jul; 59(1):184-90. PubMed ID: 22579111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of matrix metalloproteinase levels with the grade of proliferative vitreoretinopathy in the subretinal fluid and vitreous during rhegmatogenous retinal detachment.
    Symeonidis C; Papakonstantinou E; Souliou E; Karakiulakis G; Dimitrakos SA; Diza E
    Acta Ophthalmol; 2011 Jun; 89(4):339-45. PubMed ID: 19764916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of some cytokines in subretinal fluid in proliferative vitreoretinopathy and rhegmatogenous retinal detachment.
    Kenarova B; Voinov L; Apostolov C; Vladimirova R; Misheva A
    Eur J Ophthalmol; 1997; 7(1):64-7. PubMed ID: 9101198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin Generation in Vitreous and Subretinal Fluid of Patients with Retinal Detachment.
    Mulder VC; Bastiaans J; van Leuven CJM; van Meurs JC; Kluft C
    Ophthalmologica; 2018; 240(1):23-28. PubMed ID: 29617690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intercellular adhesion molecule-1 in proliferative vitreoretinopathy.
    Limb GA; Chignell AH; Cole CJ; Green WT; Webster L; Hollifield RD; Dumonde DC
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1043-8. PubMed ID: 9113001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of interleukin IL-6 levels in the subretinal fluid and the vitreous during rhegmatogenous retinal detachment.
    Symeonidis C; Androudi S; Tsaousis KT; Tsinopoulos I; Brazitikos P; Diza E; Dimitrakos SA
    Cytokine; 2012 Jan; 57(1):17-8. PubMed ID: 22070971
    [No Abstract]   [Full Text] [Related]  

  • 11. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
    Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
    Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
    Wang ZY; Shen LJ; Zhao KK; Song ZM; Qu J
    Ophthalmic Res; 2009; 42(3):138-40. PubMed ID: 19602911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine levels in subretinal fluid obtained during scleral buckling surgery after rhegmatogenous retinal detachment.
    Ricker LJ; Kijlstra A; de Jager W; Liem AT; Hendrikse F; La Heij EC
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4143-50. PubMed ID: 20335622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in vitreous fluid from eyes with retinal detachment complicated by proliferative vitreoretinopathy.
    La Heij EC; van de Waarenburg MP; Blaauwgeers HG; Kessels AG; Liem AT; Theunissen C; Steinbusch H; Hendrikse F
    Am J Ophthalmol; 2002 Sep; 134(3):367-75. PubMed ID: 12208248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100b protein levels in subretinal fluid in rhegmatogenous retinal detachment.
    Yalcinbayir O; Buyukuysal RL; Akova-Budak B; Gelisken O
    Curr Eye Res; 2012 Nov; 37(11):1030-5. PubMed ID: 22671138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipokine levels in subretinal fluid from patients with rhegmatogenous retinal detachment.
    Ricker LJ; Kijlstra A; Kessels AG; de Jager W; Hendrikse F; La Heij EC
    Exp Eye Res; 2012 Jan; 94(1):56-62. PubMed ID: 22138416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment.
    Balogh A; Milibák T; Szabó V; Nagy ZZ; Kaarniranta K; Resch MD
    BMC Ophthalmol; 2020 Dec; 20(1):491. PubMed ID: 33371882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble TNF receptors in vitreoretinal proliferative disease.
    Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenascin-C levels in the vitreous of patients with proliferative vitreoretinopathy.
    Mitamura Y; Takeuchi S; Ohtsuka K; Matsuda A; Yamamoto T; Yamamoto S; Hiraiwa N; Kusakabe M
    Ophthalmologica; 2003; 217(6):422-5. PubMed ID: 14573976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.